During my 5th-year clerkship, I gained invaluable hands-on experience in clinical settings, applying my pharmacological knowledge in real-world scenarios. I undertook several projects focusing on critical drug safety issues. One significant project assessed the impact of sacubitril/valsartan on NT-proBNP levels, potassium levels, and ejection fraction in patients with heart failure, contributing to the understanding of its therapeutic efficacy and safety profile. Additionally, I investigated levosimendan-induced diplopia, analyzing case reports and patient data to understand the incidence and mechanisms behind this adverse effect. Another study focused on rivaroxaban-induced splenic rupture, examining clinical implications and risk factors associated with this serious complication. Although my publications are still in progress, I am dedicated to bringing these findings to the forefront of clinical pharmacology. Currently, I am pursuing a* fellowship *in pharmacology, which is further expanding my expertise and preparing me for a successful career in drug safety and clinical research. I have also engaged in medical camps, which enhanced my practical skills and allowed me to serve diverse communities. Through these experiences, I have developed a robust understanding of pharmacovigilance and a passion for advancing patient safety in pharmacotherapy.